{"ticker": {"uuid": "7cf82147-ee6d-4a26-b124-7dd072ebbbe1", "symbol": "N1VO34", "name": "Novo Nordisk A/S", "exchange": "SAO", "country": "BR", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Novo Nordisk: The Selloff Looks Like A Gift - And I'm Buying (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNT05zNWxfVEpyUlF5cVowY2NUNERlbDB3djdzSVNWblJ2R09fTnFqMDlfQzJKUnJkdEJldXM3Si1kNHVsLUtMUXl4STRIOTBlUk9IS0V1ZXFrNVo5cHFCUkU5Rm9CczY0N043RElGbDZXeDNwMUFtMHRaWFhPX0FXalF6aHEwbV9OT0VXRkFyQlVOWThmUXZGUmFwNHJyZw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk A/S stock (DK0062498333): ADA obesity data and European Wegovy decisions keep focus on", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQU3N2a2VHMzA0ZWtzcnlzSUdxOVlaTFI3SWlmQXZ0VTFEU3N0a21vS1duc2lYT19GbGRaYjhKX055bnB2b01kaVc4SExObjN6NkNWejVjWDZOakF1T2I4RGZ3ZTlCQ2NIdk9zc0VxNGtiODdEYmM0aXl2dXBLQ0ZIc2ptTFZfRVVTeTgxdjFMQ0I4R3VkbGZjNXZ4YXRQRjlRcjZtVmN3c2h5RGUzZUdRTldtMHZvUnM4TjZLc1R2Z2ZVQQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brazil Clears First Generic Copy of Novo Nordisk\u2019s Ozempic Shot", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNd3Y2dzJUdFlvWDJmbUtlYVBJb01FZjJqRFJYS2FmQmtyeTRCU0hSZWdXLWlSdUlJLVlKTVdrVXlnN2NJeHFJZmFJdEtqbkU2TGstVnJlenF6VnBCVl80VlY0N3RKNE1JQW5SdFIwY180bkpGbWxDS2E0S08xSUl5bzJCTU42VjlBYmt2Z2wzbFNZU3J2UDJhUjM4QmdXUGhITlNQU2JGQWFEUFBXNHRvVktxN1E?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lilly\u2019s Strong GLP-1 Results Signal Robust Market Growth for Novo Nordisk says Barclays", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxOZ05OUTcyenRNVF9mdWNRLXZiLTBrSlVsd1RpSHVvbWo2ZFFzdlVvZDJSNkl6SUF0MzlrT1k2RWU0VUZrM0hFX282Wk5GUU1OZFVtV3ltY1hNRl9sZnRnLVF6UHduejk0bWMxOThTOEI2UEZSbG9iUVJKQnIxLXNPRVkxZzQ5VU0wNFgxcHZHeWNNNk9BNk4xSDZNYXhOeUw2NUlYa3VtLTFjT2YyOC14TS1wY2VLaGtPRlpZUVVYVDllRGF3TnMwM3dMeE5ETzMtWXFLUnhMekJwd19GenJTOQ?oc=5", "source_name": "Investing.com", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Pricing Pressure And Falling Margins Make This A Value Trap (Q1 Earnings Preview)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOenpOZExrSDlvYzdRS3FzUWN2ejlxZUh0aEpvbXBvRkFSVlg2TFktQktzMW9KX2htenVqekRvSGMzY1ZZcGVXSm5Yd1I3Wk01cHBKSFdPNTNwaVhTa3h1b1pYT2hNWkU1bVgxV2tkRktWOG9CeTJtX2ZUd3ZPQ2poaFhxT3NjakdheHUzbFcxMFhXSU15SDZSUVJPamtJVUF2NkptMmRpeE9PVHhJMEt0S2JpcnFFSUROOWc?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk's Weight Loss Doesn't Mean To Load Up (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQQS1MWUpaY19uYWFNZGhHdlZ0VzU1WFowb1BJYXp0VWt3Z19kUzlmQ1k5cnJYTVVYX3otczFHdzdBMWd1NXl4S21YSTJIR1JLcGQ2RWh0V00tOVA2WW5zV2Eza1BQb3NQRnJEMXJOa3g3V0c1Sm10VFhSNEMxVXlkQ3lkczcwNVVtUnZfWE80X2owZmc?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk Stock Forecast | Guidance Cut, Buyback, Expansion", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOX0hadEoyczFnSlhrajA3Y1VKcVlUSmczdHVfU29VWXRzUFdkMnJUSWJ3eUZST0Q5enc3c09mZFplVTUxNHBJNm1vaFRjdHBSYW92WEdrTUx1X1lnS3EzeUNVdzR2akpBRkJDanQwZ1dfVUpjRnFGSW5OMEFDLUFJZEdzb2k4elk?oc=5", "source_name": "Capital.com", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQN1NoVThlRzNMRUpFTDZnQUNJTFZZbmNKeWlWTlRweGJ5U253TUcyN216UFlfN2RNRGs1UnA1TzRaNnV1dGtaN0stTXFIdWYwLV9PTVZfWWcxR2pURXVUbU1GVWZaM3JfTFJQejVLTVZpM3gyX3lLSTRrSU9hbm1PUjdycjN0WmlrXy0xaFlGc3llaVdiNFFSdUt6R2Y2cDhhUnBVLWdaSF85Y1NVMHQwWDd4ZndJQVdZSzZQS3lTLVVqWUwzTF80bUEwV1dRMFF6RGFDMjBLQTdvMjJYT2h5RXpyRE1oRlE?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-02-04T08:00:00+00:00", "published_display": "04 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk stock tumbles after sharply lower 2026 guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQckJaaDlIcGowdm5FY0NMQlR3Rm1jeEF4RFpPc3hFdks2NGJtV1dPTnp0MGtvMFVlSDZoMnlLQjQ4QTlzY0oyLVdGV0p1alp5NXdjRThxV1BaZVcwUDJYakxqVE5vTjN2aUJWTXNzUDhWQ0FMckpURFBraG9ENElKU2FkVDVXbWFrMHAwZUpfSV9qZGdpS2dfaDJUUFVORnJwWE1DNVZwS1l4V0prTG9CV29GUQ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 30, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk Stock: Soaring Demand Met With Production Hiccup (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOZTZhMUtZb2lmMkQ0OUt6cndxZFNGYjdHN21KZGhReGp6a3lTWWpiZHBpUWN4Yko3dnh5WC00V2FpckZpZGZPV1hGMm9YeXpzNkpzQ3FrVm9NYTJ2aERrNG9maW12eTdpSnhDRGRCNXJybjgyZVdQM2wzb3hOTzk1ZjMxUTJEVVRvZ3pXNkctV1NoV01pVHFJLXJfMA?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-01-10T08:00:00+00:00", "published_display": "10 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk cuts US obesity education team as layoffs begin, say sources, online posts", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPLUl3d2ZCRUNsaTIwMllrZkZDZndQckRQZE92bE42TFB3NnBnWTd4ODFGLWwzSkhERGw4UlBZeHB3MHFfbmZGbElIZDZua0UxTktKOC1kemFmdDNhRzBlcEcwaU9pa0wxeHRXQktreko1ZFExcFVOd1hXMHBfYTdObkNKWXZXQnFWZF84WlBuUHQ0ejJiVVNkUGItcmRiY0JVZC1CMkpUSG1hU19BYmRYT0RlQnNyZ1BpQ2duTEhwWmNlRU5md0NOZUZrWmlqT2dT?oc=5", "source_name": "Reuters", "published_at": "2025-09-18T07:00:00+00:00", "published_display": "18 Sep 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Novo Nordisk: The Selloff Looks Like A Gift - And I'm Buying (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNT05zNWxfVEpyUlF5cVowY2NUNERlbDB3djdzSVNWblJ2R09fTnFqMDlfQzJKUnJkdEJldXM3Si1kNHVsLUtMUXl4STRIOTBlUk9IS0V1ZXFrNVo5cHFCUkU5Rm9CczY0N043RElGbDZXeDNwMUFtMHRaWFhPX0FXalF6aHEwbV9OT0VXRkFyQlVOWThmUXZGUmFwNHJyZw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk A/S stock (DK0062498333): ADA obesity data and European Wegovy decisions keep focus on", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQU3N2a2VHMzA0ZWtzcnlzSUdxOVlaTFI3SWlmQXZ0VTFEU3N0a21vS1duc2lYT19GbGRaYjhKX055bnB2b01kaVc4SExObjN6NkNWejVjWDZOakF1T2I4RGZ3ZTlCQ2NIdk9zc0VxNGtiODdEYmM0aXl2dXBLQ0ZIc2ptTFZfRVVTeTgxdjFMQ0I4R3VkbGZjNXZ4YXRQRjlRcjZtVmN3c2h5RGUzZUdRTldtMHZvUnM4TjZLc1R2Z2ZVQQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brazil Clears First Generic Copy of Novo Nordisk\u2019s Ozempic Shot", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNd3Y2dzJUdFlvWDJmbUtlYVBJb01FZjJqRFJYS2FmQmtyeTRCU0hSZWdXLWlSdUlJLVlKTVdrVXlnN2NJeHFJZmFJdEtqbkU2TGstVnJlenF6VnBCVl80VlY0N3RKNE1JQW5SdFIwY180bkpGbWxDS2E0S08xSUl5bzJCTU42VjlBYmt2Z2wzbFNZU3J2UDJhUjM4QmdXUGhITlNQU2JGQWFEUFBXNHRvVktxN1E?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lilly\u2019s Strong GLP-1 Results Signal Robust Market Growth for Novo Nordisk says Barclays", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxOZ05OUTcyenRNVF9mdWNRLXZiLTBrSlVsd1RpSHVvbWo2ZFFzdlVvZDJSNkl6SUF0MzlrT1k2RWU0VUZrM0hFX282Wk5GUU1OZFVtV3ltY1hNRl9sZnRnLVF6UHduejk0bWMxOThTOEI2UEZSbG9iUVJKQnIxLXNPRVkxZzQ5VU0wNFgxcHZHeWNNNk9BNk4xSDZNYXhOeUw2NUlYa3VtLTFjT2YyOC14TS1wY2VLaGtPRlpZUVVYVDllRGF3TnMwM3dMeE5ETzMtWXFLUnhMekJwd19GenJTOQ?oc=5", "source_name": "Investing.com", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Pricing Pressure And Falling Margins Make This A Value Trap (Q1 Earnings Preview)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOenpOZExrSDlvYzdRS3FzUWN2ejlxZUh0aEpvbXBvRkFSVlg2TFktQktzMW9KX2htenVqekRvSGMzY1ZZcGVXSm5Yd1I3Wk01cHBKSFdPNTNwaVhTa3h1b1pYT2hNWkU1bVgxV2tkRktWOG9CeTJtX2ZUd3ZPQ2poaFhxT3NjakdheHUzbFcxMFhXSU15SDZSUVJPamtJVUF2NkptMmRpeE9PVHhJMEt0S2JpcnFFSUROOWc?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk's Weight Loss Doesn't Mean To Load Up (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQQS1MWUpaY19uYWFNZGhHdlZ0VzU1WFowb1BJYXp0VWt3Z19kUzlmQ1k5cnJYTVVYX3otczFHdzdBMWd1NXl4S21YSTJIR1JLcGQ2RWh0V00tOVA2WW5zV2Eza1BQb3NQRnJEMXJOa3g3V0c1Sm10VFhSNEMxVXlkQ3lkczcwNVVtUnZfWE80X2owZmc?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk Stock Forecast | Guidance Cut, Buyback, Expansion", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOX0hadEoyczFnSlhrajA3Y1VKcVlUSmczdHVfU29VWXRzUFdkMnJUSWJ3eUZST0Q5enc3c09mZFplVTUxNHBJNm1vaFRjdHBSYW92WEdrTUx1X1lnS3EzeUNVdzR2akpBRkJDanQwZ1dfVUpjRnFGSW5OMEFDLUFJZEdzb2k4elk?oc=5", "source_name": "Capital.com", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQN1NoVThlRzNMRUpFTDZnQUNJTFZZbmNKeWlWTlRweGJ5U253TUcyN216UFlfN2RNRGs1UnA1TzRaNnV1dGtaN0stTXFIdWYwLV9PTVZfWWcxR2pURXVUbU1GVWZaM3JfTFJQejVLTVZpM3gyX3lLSTRrSU9hbm1PUjdycjN0WmlrXy0xaFlGc3llaVdiNFFSdUt6R2Y2cDhhUnBVLWdaSF85Y1NVMHQwWDd4ZndJQVdZSzZQS3lTLVVqWUwzTF80bUEwV1dRMFF6RGFDMjBLQTdvMjJYT2h5RXpyRE1oRlE?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-02-04T08:00:00+00:00", "published_display": "04 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk stock tumbles after sharply lower 2026 guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQckJaaDlIcGowdm5FY0NMQlR3Rm1jeEF4RFpPc3hFdks2NGJtV1dPTnp0MGtvMFVlSDZoMnlLQjQ4QTlzY0oyLVdGV0p1alp5NXdjRThxV1BaZVcwUDJYakxqVE5vTjN2aUJWTXNzUDhWQ0FMckpURFBraG9ENElKU2FkVDVXbWFrMHAwZUpfSV9qZGdpS2dfaDJUUFVORnJwWE1DNVZwS1l4V0prTG9CV29GUQ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 30, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk Stock: Soaring Demand Met With Production Hiccup (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOZTZhMUtZb2lmMkQ0OUt6cndxZFNGYjdHN21KZGhReGp6a3lTWWpiZHBpUWN4Yko3dnh5WC00V2FpckZpZGZPV1hGMm9YeXpzNkpzQ3FrVm9NYTJ2aERrNG9maW12eTdpSnhDRGRCNXJybjgyZVdQM2wzb3hOTzk1ZjMxUTJEVVRvZ3pXNkctV1NoV01pVHFJLXJfMA?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-01-10T08:00:00+00:00", "published_display": "10 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk cuts US obesity education team as layoffs begin, say sources, online posts", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPLUl3d2ZCRUNsaTIwMllrZkZDZndQckRQZE92bE42TFB3NnBnWTd4ODFGLWwzSkhERGw4UlBZeHB3MHFfbmZGbElIZDZua0UxTktKOC1kemFmdDNhRzBlcEcwaU9pa0wxeHRXQktreko1ZFExcFVOd1hXMHBfYTdObkNKWXZXQnFWZF84WlBuUHQ0ejJiVVNkUGItcmRiY0JVZC1CMkpUSG1hU19BYmRYT0RlQnNyZ1BpQ2duTEhwWmNlRU5md0NOZUZrWmlqT2dT?oc=5", "source_name": "Reuters", "published_at": "2025-09-18T07:00:00+00:00", "published_display": "18 Sep 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 69, "total_relevant": 11, "sentiment_summary": {"positive": 1, "negative": 3, "neutral": 7, "score": 47, "total": 11, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 4.15, "count": 5}, {"event": "guidance", "label": "Guidance", "weight": 1.65, "count": 3}, {"event": "earnings", "label": "Earnings", "weight": 1.45, "count": 2}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.9, "count": 1}], "positive_events": 1, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 31.62, "latest_week": "2026-07-10", "one_week_move": -6.2, "four_week_move": 14.3, "twelve_week_move": 25.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.98701, "market_dynamics_buy_signal": false, "relative_strength": -12.137359, "fair_value_gap": -42.9, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "positive", "expectation_probability": 56.028, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-6.2% over one week, +14.3% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Seeking Alpha", "count": 4}, {"label": "ad-hoc-news.de", "count": 1}, {"label": "Bloomberg.com", "count": 1}, {"label": "Investing.com", "count": 1}, {"label": "Capital.com", "count": 1}, {"label": "The Globe and Mail", "count": 1}, {"label": "marketscreener.com", "count": 1}, {"label": "Reuters", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 11}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}, {"label": "Guidance", "count": 3}, {"label": "Earnings", "count": 2}, {"label": "Macro sensitivity", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "47/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "11", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "6", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-6.2% over one week, +14.3% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Novo Nordisk: The Selloff Looks Like A Gift - And I'm Buying (NYSE:NVO)"}], "updated_at": "2026-07-18T01:15:38.708356+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}